Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

884

Role of Rap2 and its Downstream Effectors in Tumorigenesis

Hui Huang, Jiehui Di, Debao Qu

  • 1Department of Radiation Oncology and Lineberger Comprehensive Cancer Center, School of Medicine, the University of North Carolina at Chapel Hill, 101 Manning, Drive, Chapel Hill, NC 27514, USA. ypzhang@med.unc.edu.

Anti-Cancer Agents in Medicinal Chemistry
|May 19, 2015
PubMed

Insights

Rap2, a GTP-binding protein, is upregulated in many tumors and influences cancer cell processes. This review explores Rap2

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Rap2, a GTP-binding protein, is frequently upregulated in various cancers.
  • Rap2 signaling impacts critical cellular functions like cytoskeleton dynamics, proliferation, migration, and inflammation.
  • The precise role of Rap2 in tumorigenesis and its effector interactions require further investigation.

Purpose of the Study:

  • To review recent findings on the functional and physical interactions between Rap2 and its effectors.
  • To elucidate the role of Rap2 signaling pathways in cancer development.
  • To identify potential therapeutic targets within Rap2-associated networks for cancer treatment.

Main Methods:

  • Literature review of recent studies on Rap2 and its effectors.
  • Analysis of functional and physical interactions.
  • Exploration of signaling pathways involved in tumorigenesis.

Main Results:

  • Rap2's involvement in multiple cancer-associated cellular processes is highlighted.
  • Interactions between Rap2 and its effectors are crucial for its oncogenic functions.
  • Specific effector pathways contributing to tumorigenesis are identified.

Conclusions:

  • A comprehensive understanding of Rap2-effector interactions is vital for cancer therapy.
  • Targeting Rap2 signaling networks may offer novel therapeutic strategies.
  • Further research into Rap2's role in tumorigenesis can advance cancer drug discovery.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

930
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.5K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K